期刊文献+

右旋布洛芬缓释胶囊在比格犬体内的药物动力学 被引量:11

Evaluation of the pharmacokinetics of dexibuprofen modified-release capsules in Beagle dog
下载PDF
导出
摘要 目的建立一种快速、专属的HPLC UV法用于测定比格犬血浆中右旋布洛芬的浓度 ,应用本法对右旋布洛芬缓释胶囊在比格犬体内的药物动力学行为进行研究。方法 8只比格犬采用双周期交叉试验设计 ,分别口服给予右旋布洛芬缓释胶囊 (受试制剂 )及清芬片 (右旋布洛芬片 ,参比制剂 )后按时间点采集血样进行分析 ,绘制血药质量浓度 时间曲线 ,计算相关药动学参数。结果经统计分析 ,两种制剂间药动学参数AUC0 -t、AUC0 -∞ 无显著性差异 ,受试制剂峰质量浓度 ρmax低于参比制剂 ,tmax显著增大。 Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma,and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma.Method A single dose,two periods,cross-over study in 8 Beagle dogs was carried out.After an oral dose of dexibuprofen modified-release capsules (test) or Qingfen tablets (reference),the plasma samples were drawn and analyzed.Results There were no significant difference in AUC 0-t and AUC 0-∞ between the two preparations,but ρ max of the test preparation was less than the reference one and t max was obviously larger than it.Conclusion The release of the test preparation dexibuprofen modified-release capsules is modified.
出处 《沈阳药科大学学报》 CAS CSCD 2004年第3期173-176,共4页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目 (39930 180 )
关键词 右旋布洛芬 药物动力学 缓释胶囊 dexibuprofen pharmacokinetics modified-release capsules
  • 相关文献

参考文献11

  • 1Gabard B,Nirnberger G.Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen [J].Eur J Clin Pharmacol,1995,48:505-511.
  • 2Singer F,Mayrhofer F,Klein G,et al.Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAC osteoarthritis index [J].Int J C
  • 3Geisslinger G,Stock KP,Bach GL,et al.Pharmacological differences between R(-)-and S(+)-ibuprofen [J].Agents Actions,1989,27(3-4):455-457.
  • 4Sochor J,Klimes J,Sedlacek J,et al.Determination of ibuprofen in erythrocytes and plasma by high performance liquid chromatography [J].J Pharm Biomed Anal,1995,13(7):899-903.
  • 5Corpetti G,Rosignoli MT,Dionisio P.Comparative bioavilability study of two oral formulation of ibuprofen [J].Arzenim-forschung,1998,48(4):392-395.
  • 6Roger C.Validation of chromatographic methods in biomedical analysis viewpoint and discussion [J].J Chromatogr B,1997,689:175-180.
  • 7Frihmat R,Cardot JM,Boucher M,et al.Bioinversion of ibuprofen enatiomers after administration in dogs:estimation of a novel index [J].Eur J Drug Metab Pharmacokinet,2000,25:205-211.
  • 8Aiba T,Tse MM,Lin ET,et al.Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers [J].Bio Pharm Bull,1999,22:616-622.
  • 9Romero AJ,Rackley RJ,Rhodes CT.An evaluation of ibuprofen bioinversion by simulation [J].Chirality,1991,3:418-421.
  • 10成立军,赵志春.反相高效液相色谱法测定血浆中布洛芬浓度[J].中国临床药学杂志,2002,11(3):173-175. 被引量:4

二级参考文献1

共引文献3

同被引文献45

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部